Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: Roles of XIAP and cIAPs

Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) is a promising anti-cancer agent because it shows apoptosis-inducing activity in transformed, but not in normal cells. As with most anti-cancer agents, however, its clinical use is restricted by either inherent or acquired resistance by...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Finlay, Darren, Vamos, Mitchell, González-López, Marcos, Ardecky, Robert J., Ganji, Santhi Reddy, Yuan, Hongbin, Su, Ying, Cooley, Trina R., Hauser, Curt T., Welsh, Kate, Reed, John C., Cosford, Nicholas D. P., Vuori, Kristiina
פורמט: Artigo
שפה:Inglês
יצא לאור: 2013
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3947130/
https://ncbi.nlm.nih.gov/pubmed/24194568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-0153
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים